Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Additional phase I/II trial results for MEDI-493

April 10, 1997

Antimicrobial/antineoplastic antibiotic discovered by Ajinomoto

April 9, 1997

Hybridon receives clearance to initiate further GEM-132 trials

April 8, 1997

Antibacterial mupirocin sulfamates from SmithKline Beecham

April 7, 1997

Novel antifungal discovered by Takara Shuzo

April 4, 1997

Cubist prepares inhibitors of isoleucyl-tRNA synthetase

April 4, 1997

Phase I/II results of MedImmune's MEDI-493 reported

April 3, 1997

IVAX's generic acyclovir tentatively approved

April 3, 1997

Stromectol available in U.S. for parasitic infections

April 3, 1997

Uriach discloses new antifungal agents

April 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...